about
Sieve-based device for MALDI sample preparation. I. Influence of sample deposition conditions in oligonucleotide analysis to achieve significant increases in both sensitivity and resolution.Aspects of the role of surfaces in ionization processes.Sieve-based device for MALDI sample preparation. II. Instrumental parameterization.Elemental labeling for the identification of proteinaceous-binding media in art works by ICP-MS.Clinical predictive circulating peptides in rectal cancer patients treated with neoadjuvant chemoradiotherapy.Chemical aspects of the primary ionization mechanisms in matrix-assisted laser desorption ionization.Matrix-assisted laser desorption/ionization, nanostructure-assisted laser desorption/ionization and carbon nanohorns in the detection of antineoplastic drugs. 1. The cases of irinotecan, sunitinib and 6-alpha-hydroxy paclitaxel.Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression.Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements.Field-assisted paper spray mass spectrometry for the quantitative evaluation of imatinib levels in plasma.Some thoughts on electrospray ionization mechanisms.Predictive response biomarkers in rectal cancer neoadjuvant treatment.Mass spectrometry in the pharmacokinetic studies of anticancer natural products.Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior?Claisen rearrangement induced by low-energy collision of ESI-generated, protonated benzyloxy indoles.Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research.Diagnostic Devices for Circulating Biomarkers Detection and Quantification.Field-assisted paper spray mass spectrometry for therapeutic drug monitoring: 1. the case of imatinib in plasma.Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.Surface-activated chemical ionization ion trap mass spectrometry for the analysis of cocaine and benzoylecgonine in hair after extraction and sample dilution.Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker.Medium chain fatty acids in intrauterine growth restricted and small for gestational age pregnanciesThe development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: preliminary resultsSome Applications of Liquid Chromatography-Mass Spectrometry in the Biomedical FieldAdvanced spectroscopic detectors for identification and quantification: Mass spectrometryAdvanced Spectroscopic Detectors for Identification and QuantificationOn the coupling of ion-exchange chromatography to surface-activated chemical ionization in the analysis of highly polar metabolites in diluted urine samplesNanovectors Design for Theranostic Applications in Colorectal CancerEvidence of noncovalent complexes in some natural extracts: Ceylon tea and mate extractsTryptophan Metabolism as Source of New Prognostic Biomarkers for FAP Patients
P50
Q33352737-2E5667D0-C81D-46F2-B10F-84E1114A92CDQ33441942-DB9FBE84-5E04-4AD6-8B51-7FE7D28B0659Q33504712-BDE47485-0DCC-4EF2-B809-9F1788BB001EQ34120148-D2DFE5F3-4980-4661-9F6F-51D43BAC9ED0Q35529674-10CB8309-6F9C-4239-AEC4-CC3FF6CDCE1EQ35612644-CE9CD165-CF73-4002-9622-4C3C71173E5AQ35612651-DDADEB24-5CDF-4233-AFFD-5DE9183881E4Q35778619-972B0022-2FD8-4159-8088-04FEAC02280EQ35899548-CB89CE20-EB9D-42C7-8712-8EB6F5EE919BQ36033002-DF43ED88-E96D-4BF1-8D33-F2C6EB067E39Q36203262-B1433FF0-5141-4F2C-87CB-7C7DAA50F959Q37896414-4809124C-375F-46D7-81EF-409DCF210EEBQ38175761-AD95F155-C93D-4734-A0ED-1971CB400A83Q38568180-0CD41EFF-FFE0-4B6D-933E-3E0BD47EADD5Q38989294-92FD9F7E-B523-4758-8CFD-FE419D41861DQ46846361-4D269EFC-0C44-4156-B594-0ECD7BE5A771Q47246744-279A00F4-10A5-471F-AC40-3A626CFB6A0DQ47336899-333C6DBD-E8AB-42A6-8243-4FBA60AC1DC4Q48174042-7C7F59DB-D8FD-4AC5-9D30-85C8E3F55A72Q48239826-2A650256-8CF6-4B51-A4C2-FD2B6AC687C4Q48585719-CE5E2E5E-CC17-4FD5-BFCD-EF10DD8D6B30Q53066764-D0408AF4-6FFF-4823-A9E8-0CD5825E6DE8Q63884141-823D6E9D-7FF4-4389-BFA7-9AE48B8AF532Q63884143-8873D3C4-0DF6-4039-B2E0-1776CCE8F9E7Q63884173-7AEB3525-FCF2-4939-9706-201B0D3D94C7Q63884175-029F6107-8D24-4473-B0A0-691925A28C68Q63884178-C67263A5-89A4-4DA9-B8F6-ABAE7E5E3A7AQ63884183-EB12FC1E-6827-46E5-9A95-57B5894B00D6Q90991910-742BCA76-AE28-45A1-9CC7-9679264A994AQ90995135-6472441A-BCD4-49BF-8EA2-50F7D2D3D0BDQ91668541-746E8C7B-881C-402A-A5ED-A142E23858CB
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Crotti
@ast
Sara Crotti
@en
Sara Crotti
@es
Sara Crotti
@nl
type
label
Sara Crotti
@ast
Sara Crotti
@en
Sara Crotti
@es
Sara Crotti
@nl
prefLabel
Sara Crotti
@ast
Sara Crotti
@en
Sara Crotti
@es
Sara Crotti
@nl
P106
P21
P31
P496
0000-0001-6602-5153